Tyiesha Brown, MD
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor (Joint Appointment), Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Assistant Professor, General Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2019 | American University of Antigua, St John's, Saint John Parish, AG, Doctor of Medicine |
| 2011 | Texas Tech University System, Lubbock, Texas, US, Cell and Molecular Biology, Bachelor of Science |
Postgraduate Training
| 2023-2026 | Fellow Physician, Hematology and Oncology, University of California San Francisco Medical Center, San Francisco, California |
| 2020-2023 | Resident Physician, Internal Medicine, Louisiana State University in Shreveport, Shreveport, Louisiana |
Licenses & Certifications
| 2026 | Texas Medical Board |
| 2026 | BLS |
| 2025 | American Board of Internal Medicine-Medical Oncology |
| 2023 | Medical Board of California |
| 2023 | American Board of Internal Medicine |
| 2020 | Louisiana State Board of Medical Examiners |
Experience & Service
Other Professional Positions
Hematology/Oncology Chief Fellow, Hematology/Oncology, University of California San Francisco Medical Center, San Francisco, California, 2024 - 2025
Research and Career Mentor, University of California San Francisco Medical Center, San Francisco, California, 2023 - Present
Internal Medicine Chief Resident, Louisiana State University in Shreveport, Shreveport, Louisiana, 2022 - 2023
Resident Council President, Louisiana State University in Shreveport, Shreveport, Louisiana, 2022 - 2023
Medical Scholar Tutor/Mentor, American University of Antigua, St John's, Saint John Parish, 2019 - 2020
Medical Scholar Tutor, American University of Antigua, St John's, Saint John Parish
Extramural Institutional Committee Activities
Member, Community Connection Committee, Louisiana State University in Shreveport, 2022 - 2023
Member, Ambulatory Quality Improvement Committee, Louisiana State University in Shreveport, 2021 - 2023
Member, Cultural Competency Committee, Louisiana State University in Shreveport, 2021 - 2023
Honors & Awards
| 2023 - Present | Resident Appreciation for dedication to Cultural Competency, Louisiana State University in Shreveport |
| 2023 - Present | Gold Humanism Honor Society, Louisiana State University in Shreveport |
| 2023 | Continuity Clinic Excellence Award, Louisiana State University in Shreveport |
| 2019 - Present | Magna Cum Laude, Top 5 of Graduating Class, American University of Antigua |
Professional Memberships
Selected Presentations & Talks
National Presentations
- End-of-life care in hospitalized patients with lung cancer. Poster. American Society for Radiation Oncology.
- Incidence of VTE in pregnant women with sickle cell gene mutations: a retrospective database analysis. Poster. American Society of Hematology.
International Presentations
- 2025. Detection of circulating tumor DNA prior to neoadjuvant osimertinib in EGFR-mutated NSCLC correlates with EFS. Poster. World Conference on Lung Cancer. Barcelona, ES.
Selected Publications
Peer-Reviewed Articles
- Brown T, Lara MS, Jiang F, Garon EB, Goldman JW, Riess JW, Blakely CM. Brief Report-Combination Capmatinib and Trametinib in Metastatic MET-driven Non-Small Cell Lung Cancer. JTO Clinical and Research Reports, 2026. e-Pub 2026.
- Fukuda K, Nanjo S, Takeuchi S, Chakrabarti T, Brown T, Dev Sahadevan SW, Arai S, Sato S, Kotani H, Nishiyama A, Sakaguchi H, Ohtsubo K, Taniguchi H, Blakely CM, Bivona TG, Yano S. Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer. J Thorac Oncol 20(10):1459-1474, 2025. e-Pub 2025. PMID: 40518016.
- Nassar AH, Kim C, Adeyelu T, Bou Farhat E, Abushukair H, Rakaee M, Matteson K, Lau SF, Takabe Y, Ocejo A, Ardeshir-Larijani F, Leal T, Ramalingam S, Alam S, Gray JE, Hicks J, Kaldas D, Baena J, Berjaga MZ, Nana FA, Grohe C, Leuders H, Citarella F, Cortellini A, Mingo EC, Pancirer D, Das M, Ellis-Caleo TJ, Cheung JM, Lin JJ, Watson AS, Camidge DR, Sridhar A, Parikh K, Crowley F, Marron TU, Aggarwal V, Ahmed M, Sankar K, Kawtharany H, Zhang J, Owen DH, Li M, Nagasaka M, Pinato DJ, Awosika N, Alhamad K, Puri S, Zaman U, Gupta DM, Lau C, Khan H, Liauw J, Velazquez AI, Brown T, Moliner L, Mosteiro M, Rocha P, Evans M, Vanderwalde A, Elliott A, Nieva J, Lopes G, Ma PC, Borghaei H, Lee M, Young L, Aljumaily R, Mirza H, Kwiatkowski DJ, Herbst RS, Flavell RA, Naqash AR, Chiang AC. Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma. Nat Commun 16(1):7717, 2025. e-Pub 2025. PMID: 40830141.
- Brown TS, Lakra R, Master S, Ramadas P. Sickle Cell Trait: Is It Always Benign?. J Hematol 12(3):123-127, 2023. e-Pub 2023. PMID: 37435414.
- Brown TS, Vo G, Charoenpong P. An Unusual Case of Macrophage Activation Syndrome (MAS)- Hemophagocytic Lymphohistiocytosis (HLH) Triggered by Necrotizing Autoimmune Myopathy. Cureus 15(5):e38501, 2023. e-Pub 2023. PMID: 37273328.
- Brown T, Mussarat A, Pant A, Kulkarni S. Non-small cell lung cancer presenting as back cyst. Proc (Bayl Univ Med Cent) 36(1):87-88, 2023. e-Pub 2023. PMID: 36578608.
- Grewal US, Brown T, Mudigonda GR, Davila-Chapa C, Thotamgari SR, Crooms C, Singh JS, Mahadevan R. Using Shared Medical Appointments for Delivering Patient-Centered Care to Cancer Survivors: A Feist-Weiller Cancer Center Pilot Study. J Patient Exp 9:23743735211069834, 2022. e-Pub 2022. PMID: 35071749.
- Ananthaneni A, Grewal US, Brown TS, et al. ADAMTS13 overtesting in hospitalized patients with suspected TTP. Blood 140(S1):5019-5020, 2022. e-Pub 2022.
- Gaddam SJ, Brown TS, et al. Recurrent VTE with DOACs and BMI: a single-institution study 140(S1):11376–11377, 2022. e-Pub 2022.
Abstracts
- Brown T, Gubens M, Mulvey C, Rotow JK, Riess JW, Patil T, Kratz JR, Blakely CM. Detection of ctDNA Prior to Neoadjuvant Osimertinib Treatment Correlates With Decreased EFS in EGFR-Mutated NSCLC. IASLC, 2025. e-Pub 2025.
- Shaukat R, Blanc KL, Brown TS, Robin A, Martinez S, Walton J, Gutta P, Shi R, Master SR, Mansour RP. Incidence of VTE in Pregnant Women with Sickle Cell Gene Mutation(s): A Retrospective Database Analysis. ASH, 2022. e-Pub 2022.
- Brown TS, Grewal U, Thotamgari SR, Ananthaneni AK, Burnett C, Vutukuri S, Beedupalli K. End of Life Care in Hospitalized Patients With Lung Cancer. ASTRO, 2022. e-Pub 2022.
Letters to the Editor
- Gaddam SJ, Grewal US, Brown TS, Salard M, Bhargava P, Iqbal F, Thotamgari SR, Kantamani D, Master S, Ramadas P. Impact of body mass index on venous thromboembolism recurrence with direct oral anticoagulants. Am J Emerg Med 67: 187-188, 2023.
- Grewal US, Mudigonda GR, Davila-Chapa C, Brown T, Mahadevan R. Shared Medical Appointments May Be Beneficial in Mitigating Guilt among Cancer Survivors. J Palliat Med, 2022.
- Grewal US, Mudigonda GR, Davila-Chapa C, Brown T, Mahadevan R. Letter to the Editor: Shared Medical Appointments May Be Beneficial in Mitigating Guilt among Cancer Survivors. J Palliat Med 25: 1328-1329, 2022.
- Grewal US, Gaddam SJ, Thotamgari SR, Brown T, Beedupalli K, Mills GM. Hospitalized patients are needlessly over-tested for heparin induced thrombocytopenia. Eur J Intern Med 102: 128-130, 2022.
- Brown T, Grewal US, Ananthaneni AK, Thotamgari SR, Beedupalli K. Letter to the Editor: Poor Access to Ambulatory Palliative Care and Needless Aggressive Care toward the End of Life among Patients with Lung Cancer. J Palliat Med 25: 698-699, 2022.
Patient Reviews
CV information above last modified October 01, 2026